A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine
DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 401–500 of 953

  1. Role of social responsibility in prevention of the COVID-19 outbreak from systems thinking perspective
    Seyed Mojtaba Hosseini Bamakan, Mohammad Jafar Haddadpoor Jahromi · 2020 · Public Health
  2. Coronavirus Disease 2019 Temperature Trajectories Correlate With Hyperinflammatory and Hypercoagulable Subphenotypes
    Sivasubramanium V. Bhavani, Philip A. Verhoef, Cheryl L. Maier, Chad J. Robichaux, William F. Parker, Andre L. Holder, Rishikesan Kamaleswaran, May Dongmei Wang, Matthew M. Churpek, Craig M. Coopersmith · 2022 · Critical Care Medicine
  3. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
    Michael J. Peluso, Joanna L. Donatelli, Timothy J. Henrich · 2021 · Translational research
  4. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents
    Hing Wai Tsang, Gilbert T. Chua, Kelvin Kai‐Wang To, Joshua Sung Chih Wong, Wenwei Tu, Janette Kwok, Wilfred Hing Sang Wong, Xiwei Wang, Yanmei Zhang, Jaime S. Rosa Duque et al. · 2021 · Frontiers in Immunology
  5. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities
    Hamed Fouladseresht, Atefe Ghamar Talepoor, Nahid Eskandari, Marzieh Norouzian, Behrooz Ghezelbash, Mohammad Reza Beyranvand, Seyed Aria Nejadghaderi, Kristin Carson‐Chahhoud, Ali‐Asghar Kolahi, Saeid Safiri · 2022 · Frontiers in Immunology
  6. The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
    Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor Orifovna Bafoeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei et al. · 2022 · Journal of Medical Virology
  7. Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data
    Zehua Dong, Qiyu Yan, Wenxiu Cao, Zhixian Liu, Xiaosheng Wang · 2022 · Frontiers in Immunology
  8. Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease
    Geoffrey Garcia, S. Colomer, Alexandre Duvignaud, Etienne Clequin, Charles Dussiau, David‐Alexandre Trégouët, Denis J.-M. Malvy, Renaud Prével, Atika Zouine, Isabelle Pellegrin et al. · 2024 · Journal of Translational Medicine
  9. Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection
    Ioannis V. Kostopoulos, Nikolaos Orologas‐Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Ioannis Ntanasis‐Stathopoulos, Ioanna Charitaki, Eleni Korompoki, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos et al. · 2021 · Microorganisms
  10. Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19
    Nicholas S. Stoy · 2021 · Frontiers in Immunology
  11. A putative “chemokine switch” that regulates systemic acute inflammation in humans
    Nabil Azhar, Rami A. Namas, Khalid Almahmoud, Akram M. Zaaqoq, Othman Abdul Malak, Derek A. Barclay, Jinling Yin, Fayten El-Dehaibi, Andrew Abboud, Richard L. Simmons et al. · 2021 · Scientific Reports
  12. Sex-biased mechanisms of cardiovascular complications in COVID-19
    Georgios Kararigas · 2021 · Physiological Reviews
  13. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
    Rebecca J. Lee, Oskar Wysocki, Talvinder Bhogal, Rohan Shotton, Ann Tivey, Angelos Angelakas, T. Aung, Kathryn Banfill, Mark A Baxter, H. Boyce et al. · 2021 · ESMO Open
  14. Neutrophil kinetics and function after major trauma: A systematic review
    Liam DB Finlay, Andrew Conway Morris, Adam M. Deane, Alexander J. T. Wood · 2021 · World Journal of Critical Care Medicine
  15. Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19
    Na Wang, Marta Vuerich, Ahmadreza Kalbasi, Jonathon J. Graham, Eva Csizmadia, Zachary Manickas-Hill, Ann E. Woolley, Clément N. David, Eric M. Miller, Kara M. Gorman et al. · 2021 · iScience
  16. Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
    Rebecca Svanberg Teglgaard, Cameron Ross MacPherson, Adrian G. Zucco, Rudi Agius, Tereza Faitová, Michael Asger Andersen, Caspar da Cunha‐Bang, Lars Klingen Gjærde, Maria Elizabeth Engel Møller, Patrick Terrence Brooks et al. · 2022 · Communications Medicine
  17. Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19
    Qiuchen Zhao, Zhenyang Yu, Shengyuan Zhang, Xu-Rui Shen, Hao Yang, Yangyang Xu, Yang Liu, Lin Yang, Qing Zhang, Jiaqi Chen et al. · 2022 · iScience
  18. Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
    Shin‐ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, Kanako Shimizu · 2022 · Inflammation and Regeneration
  19. Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection
    Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney · 2021 · The FASEB Journal
  20. Dysregulation in erythrocyte dynamics caused by SARS-CoV-2 infection: possible role in shuffling the homeostatic puzzle during COVID-19
    Michelle Mendanha Mendonça, Kellen Rosa da Cruz, Denise da Silva Pinheiro, Gean Carlos Alves Moraes, Patrı́cia Maria Ferreira, Marcos Luiz Ferreira Neto, Eduardo Sérgio da Silva, Reggiani Vilela Gonçalves, Gustavo Rodrigues Pedrino, James Oluwagbamigbe Fajemiroye et al. · 2022 · Hematology Transfusion and Cell Therapy
  21. SARS-CoV-2 Induces Cytokine Responses in Human Basophils
    Srinivasa Reddy Bonam, Camille Chauvin, Laurine Levillayer, Mano Joseph Mathew, Anavaj Sakuntabhai, Jagadeesh Bayry · 2022 · Frontiers in Immunology
  22. Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
    Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andrés F. Vallejo, Stephen Poole, Nathan James Brendish, Xiaofeng Dong, Catherine S. Hartley, John W. Holloway, Jane S. Lucas et al. · 2022 · Frontiers in Immunology
  23. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial
    Rafael León‐López, Sheila Cárcel, Laura Limia Pérez, Alberto Romero-Palacios, María Concepción Fernández-Roldán, Eduardo Aguilar-Alonso, Inés Pérez Camacho, Jesús Rodríguez‐Baño, Nicolás Merchante, Julián Olalla et al. · 2020 · BMJ Open
  24. Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
    Emiko Desvaux, Antoine Hamon, Sandra Hubert, Cheïma Boudjeniba, Bastien Chassagnol, Jack Swindle, Audrey Aussy, Laurence Laigle, Jessica Laplume, Perrine Soret et al. · 2021 · PLoS ONE
  25. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
    Ivo Udovičić, Ivan Stanojević, Dragan Djordjevic, Snježana Zeba, Goran Rondović, Tanja Abazovic, Srdjan Lazic, Danilo Vojvodić, Kendrick To, Džihan Abazović et al. · 2021 · Journal of Clinical Medicine
  26. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection
    Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra Shantaram Padwad, Sanjay Kumar · 2022 · Inflammopharmacology
  27. SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice
    Rute Gonçalves, Joana Couto, Pedro Ferreirinha, José Maria Costa, Diogo Silvério, Marta Silva, Ana Isabel Fernandes, Pedro Madureira, Nuno L. Alves, Sofia Lamas et al. · 2023 · iScience
  28. Multivariate indicators of disease severity in COVID-19
    Joe Bean, Leticia Kuri-Cervantes, Michael Pennella, Michael R. Betts, Nuala J. Meyer, Wail M. Hassan · 2023 · Scientific Reports
  29. Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia
    Bryan S. Blette, Anders Granholm, Fan Li, Manu Shankar‐Hari, Theis Lange, Marie Warrer Munch, Morten Hylander Møller, Anders Perner, Michael Oscar Harhay · 2023 · Scientific Reports
  30. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity
    Martin Potts, Alice Fletcher-Etherington, Katie Nightingale, Federica Mescia, Laura Bergamaschi, Fernando J. Calero‐Nieto, Robin Antrobus, James C. Williamson, Harriet T. Parsons, Edward L. Huttlin et al. · 2023 · Cell Reports
  31. A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019
    Ludovico De Stefano, Francesca Bobbio‐Pallavicini, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti · 2020 · Frontiers in Immunology
  32. Overlapping and distinct features of viral and allergen immunity in the human lung
    James A. Harker, Clare M. Lloyd · 2021 · Immunity
  33. Complexity of immune responses in COVID-19
    Michael William Mather, Laura Jardine, Benjamin James Talks, Louis C. S. Gardner, Muzlifah A. Haniffa · 2021 · Seminars in Immunology
  34. The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges
    Anke Janssen, Eline van Diest, Anna Vyborova, Lenneke Schrier, Anke H. W. Bruns, Zsolt Sebestyén, Trudy Straetemans, Moniek A. de Witte, Jurgen H. E. Kuball · 2022 · Viruses
  35. Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections—Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection
    Anna Andreevna Starshinova, Igor Vladimirovich Kudryavtsev, Anna M. Malkova, Yulia S. Zinchenko, Vadim Evgenievich Karev, Dmitry Anatolievich Kudlay, Angela Glushkova, A.Ya. Starshinova, José Domínguez, Raquel Villar-Hernández et al. · 2022 · International Journal of Molecular Sciences
  36. Disrupted Peyer’s Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus
    Silvia Cellone Trevelin, Suzanne Pickering, Katrina Todd, Cynthia Bishop, Michael J. Pitcher, José Garrido‐Mesa, Lucia Montorsi, Filomena Spada, Nedyalko Petrov, Anna C. Green et al. · 2022 · Frontiers in Immunology
  37. Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
    Susan R. Conway, Michael Daniel Keller, Catherine M. Bollard · 2022 · Blood
  38. Identification of serum metabolites enhancing inflammatory responses in COVID-19
    Chen‐Song Zhang, Bingchang Zhang, Mengqi Li, Xiaoyan Wei, Kai Gong, Zhiyong Li, Xiangyang Yao, Jianfeng Wu, Cixiong Zhang, Mingxia Zhu et al. · 2022 · Science China Life Sciences
  39. Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma
    Nardhy Gomez‐Lopez, Roberto J. Romero, María Fernanda Escobar, Javier Andrés Carvajal, Maria Paula Echavarría, Ludwig L. Albornóz, Daniela Nasner, Derek Miller, Dahiana Marcela Gallo, José Galaz et al. · 2023 · Communications Medicine
  40. Convalescent Plasma in Critically ill Patients with Covid-19
    The REMAP-CAP Investigators, Lise J Estcourt · 2021 · medRxiv
  41. Drug repositioning by merging active subnetworks validated in cancer and COVID-19
    Marta Lucchetta, Marco Pellegrini · 2021 · Scientific Reports
  42. Clinical and Immunological Predictors of Hemorrhagic Fever with Renal Syndrome Outcome during the Early Phase
    Geum‐Young Lee, Won‐Keun Kim, Jin Sun No, Yongjin Yi, Hayne Cho Park, Jaehun Jung, Seungchan Cho, Jingyeong Lee, Seung‐Ho Lee, Kyungmin Park et al. · 2022 · Viruses
  43. An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease
    Niv Samuel Mastboim, Alon Angel, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, Michal Rosenberg, Yael Israeli, Mary Hainrichson, Noa Avni et al. · 2023 · Cytokine
  44. RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?
    Sophia K. Stegeman, Olena Kourko, Heather Amsden, Isabella E. Pellizzari-Delano, John E. Mamatis, Madison Roth, Che C. Colpitts, Katrina Gee · 2025 · Journal of Innate Immunity
  45. Paediatric research in the times of COVID-19
    Paul Fleming, Chris Gale, Eleanor J. Molloy, Saul N. Faust, Kate Costeloe, Edmund Juszczak, Charles Christoph Roehr · 2021 · Pediatric Research
  46. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
    Amy Susan Codd, Stephanie Jean Hanna, Ewoud Bernardus Compeer, Felix Clemens Richter, Eleanor J. Pring, Ester Gea-Mallorquí, Mariana Borsa, Owen R. Moon, David Oliver Scourfield, David Ahern et al. · 2021 · Oxford Open Immunology
  47. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
    Jackwee Lim, Kia Joo Puan, Liang Wei Wang, Karen Wei Weng Teng, Chiew Yee Loh, Kim Peng Tan, Guillaume Carissimo, Yi‐Hao Chan, Chek Meng Poh, Cheryl Yi‐Pin Lee et al. · 2021 · Frontiers in Immunology
  48. Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
    Rowan S. M. Howell, Matthew A. Clarke, Ann‐Kathrin Reuschl, Tianyi Chen, Sean Abbott-Imboden, Mervyn Singer, David M. Lowe, Clare L. Bennett, Benny Chain, Clare L. Jolly et al. · 2022 · npj Digital Medicine
  49. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis
    Amal F. Alshammary, Jawaher Alsughayyir, Khalid Khalaf Alharbi, Abdulrahman M. Alsulaiman, Haifa F. Alshammary, Heba Alshammary · 2022 · Frontiers in Medicine
  50. Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia
    Kseniya A. Rubina, Anna Shmakova, Шабанов Аслан Курбанович, Yulii Andreev, Н. В. Боровкова, В. В. Кулабухов, Anatoly K. Evseev, К. А. Попугаев, Sergey S. Petrikov, Ekaterina V. Semina · 2022 · PLoS ONE
  51. Druggable targets and therapeutic development for COVID-19
    Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen · 2022 · Frontiers in Chemistry
  52. CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
    Alessandra Noto, Victor Joo, Antonio Mancarella, Madeleine Suffiotti, Céline Pellaton, Craig W. Fenwick, Matthieu Perreau, Giuseppe Pantaleo · 2022 · Viruses
  53. RSV-induced expanded ciliated cells contribute to bronchial wall thickening
    Sattya Narayan Talukdar, Jaspreet Kaur Osan, Ken Ryan, Bryon D. Grove, Danielle S. Perley, Bony De Kumar, Shirley Yang, Sydney Dallman, Lauren Hollingsworth, Kristina L. Bailey et al. · 2023 · Virus Research
  54. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs
    Reyhaneh Rasizadeh, Parisa Shiri Aghbash, Javid Sadri Nahand, Taher Entezari‐Maleki, Hossein Bannazadeh Baghi · 2023 · Virology Journal
  55. DCs-based therapies: potential strategies in severe SARS-CoV-2 infection
    Jian Han, Jiazhi Sun, Guixin Zhang, Hailong Chen · 2020 · International Journal of Medical Sciences
  56. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
  57. Antibody levels remain high to one-year’s follow-up after moderate and severe COVID-19, but not after mild cases
    Anne Kallaste, Kalle Kisand, Agnes Aart, Kai E. Kisand, Pärt Peterson, Margus Lember · 2021 · Scandinavian Journal of Infectious Diseases
  58. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
    Christophe Capelle, Séverine Ciré, Olivia Domingues, Isabelle Ernens, Fanny Hedin, Aurélie Fischer, Chantal J. Snoeck, Wim Ammerlaan, Maria Konstantinou, Kamil Grzyb et al. · 2022 · Cell Reports Medicine
  59. Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19
    Antonios Kritikos, Sophie Gabellon, Jean‐Luc Pagani, Matteo Monti, Pierre–Yves Bochud, Oriol Manuel, Alix T. Coste, Gilbert Greub, Matthieu Perreau, Giuseppe Pantaleo et al. · 2022 · Viruses
  60. Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
    Miriam Echaide, Ibone Labiano, Marina Delgado, Ángela Fernández de Lascoiti, Patricia Ochoa, Maider Garnica, Pablo Ramos, Luisa Chocarro, Leticia Fernández, Hugo Arasanz et al. · 2022 · Cancers
  61. Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2
    Mengwen Huang, XingChao Pan, Xinling Wang, Qingfei Ren, Bei Tong, Xianchi Dong, Gaoxiang Ge, Lu Lu, Shibo Jiang, Jianfeng Chen · 2023 · Signal Transduction and Targeted Therapy
  62. Serodominant SARS-CoV-2 Nucleocapsid Peptides Map to Unstructured Protein Regions
    Jacob P. Vandervaart, Nicole L. Inniss, Ted Ling-Hu, G. Minasov, Grant Wiersum, Mónica Rosas‐Lemus, L. Shuvalova, Chad J. Achenbach, Judd F. Hultquist, K.J.F. Satchell et al. · 2023 · Microbiology Spectrum
  63. Myeloid dysregulation and therapeutic intervention in COVID-19
    Runxia Gu, Tianyang Mao, Lu Qiao, Tina Tianjiao Su, Jun Wang · 2021 · Seminars in Immunology
  64. Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.
    Noriyuki Suzaki, Akio Hiraki, Nagio Takigawa, Hiroshi Ueoka, Yasushi Tanimoto, Toshiyuki Kozuki, Masahiro Tabata, Arihiko Kanehiro, Katsuyuki Kiura, Mitsune Tanimoto · 2006 · PubMed
  65. Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
    Guihai Liu, Elie Antoun, Anastasia Fries, Xuan Yao, Zixi Yin, Danning Dong, Wenbo Wang, Peter A. C. Wing, Wanwisa Dejnirattisa, Piyada Supasa et al. · 2025 · Nature Communications
  66. Cytokine response over the course of COVID-19 infection in pregnant women
    Daniel B. Rosen, Elisabeth A. Murphy, Ron S. Gejman, Allyson M. Capili, Rachel L. Friedlander, Sophie Rand, Kristen A. Cagino, Shannon M. Glynn, Kathy C. Matthews, Jeffrey M. Kubiak et al. · 2022 · Cytokine
  67. New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
    Vasiliki Rapti, Θωμάς Τσαγανός, Ioannis Athanasios Vathiotis, Nikolaos Konstantinos Syrigos, Peifeng Li, Garyphallia Poulakou · 2022 · Vaccines
  68. Extracellular vesicles in COVID-19 convalescence can regulate T cell metabolism and function
    M. George, Jenifer Sanchez, Christina M. Rollings, David J. Fear, Peter Miles Irving, Linda V. Sinclair, Anna Schurich · 2023 · iScience
  69. The Influence of Cross-Reactive T Cells in COVID-19
    Peter J. Eggenhuizen, Joshua Daniel Ooi · 2024 · Biomedicines
  70. An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
    Roger D. Pechous, Priyangi A. Malaviarachchi, Srijon Kaushik Banerjee, Stephanie D. Byrum, Duah Alkam, Alireza Ghaffarieh, Richard C. Kurten, Joshua L. Kennedy, Xuming Zhang · 2024 · Journal of Virology
  71. Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
    Evangelos Bellos, Dilys Santillo, Pierre Vantourout, Heather Jackson, Amédine Duret, Henry Hearn, Yoann Seeleuthner, Estelle Talouarn, Stephanie Hodeib, Harsita Patel et al. · 2024 · The Journal of Experimental Medicine
  72. Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients
    Meijuan Zheng, Yong Gao, Siyu Liu, Dandan Sun, Fan Yang, Lu Zong, Min Zhang, Zhigang Tian, Yuanhong Xu, Haoyu Sun · 2020 · Cellular and Molecular Immunology
  73. Overlapping B cell pathways in severe COVID-19 and lupus
    Amy Darise Farris, Joel M. Guthridge · 2020 · Nature Immunology
  74. Dysregulation of the leukocyte signaling landscape during acute COVID-19
    Isaiah R. Turnbull, Anja G. Fuchs, Kenneth E. Remy, Michael Patrick Kelly, Elfaridah P. Frazier, Sarbani Ghosh, Shin-Wen Chang, Monty B. Mazer, Annie Hess, Jennifer M. Leonard et al. · 2022 · PLoS ONE
  75. Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
    Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, Lucy Thorne, Manisha R. Ummadi, Chengjin Ye, Romel Rosales, Adrian Pelin, Jyoti Batra, Gwendolyn Μ. Jang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  76. T-cell exhaustion in COVID-19: what do we know?
    Roderick Chen-Camaño, Rodrigo DeAntonio, Sandra López‐Vergès · 2025 · Frontiers in Immunology
  77. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model
    Judy Day, Soojin Park, Benjamin L. Ranard, Harinder Singh, Carson C. Chow, Yoram Vodovotz B · 2021 · Frontiers in Immunology
  78. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients
    Susan Ashrafzadeh‐Kian, M.R. Campbell, J.C. Aguirre, J. Walsh, Attila Kumánovics, Garrett Jenkinson, Piero Rinaldo, Melissa R. Snyder, Alicia Algeciras‐Schimnich · 2021 · Cytokine
  79. γδ T Cells in Emerging Viral Infection: An Overview
    Eleonora Cimini, Chiara Agrati · 2022 · Viruses
  80. Lung T cell response in COVID-19
    Mehrnoush Hadaddzadeh Shakiba, Ioanna D. Gemünd, Marc Beyer, Lorenzo Bonaguro · 2023 · Frontiers in Immunology
  81. Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy
    Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yujun Dong · 2023 · Annals of Hematology
  82. Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19
    Lucía Carrau, Justin J. Frere, Ilona Golynker, Álvaro Fajardo, Cristobal F. Rivera, Shu Horiuchi, Tyler Roonprapunt, Judith M. Minkoff, Daniel Blanco-Melo, Benjamin Robert tenOever · 2023 · Science Signaling
  83. A unique cytotoxic CD4 + T cell‐signature defines critical COVID‐19
    Sarah Baird, Caroline L. Ashley, Felix Marsh‐Wakefield, Sibel Alca, Thomas M. Ashhurst, Angela L. Ferguson, Hannah Lukeman, Claudio Counoupas, Jeffrey John Post, Pam Koneçny et al. · 2023 · Clinical & Translational Immunology
  84. Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury
    Dongfang Lv, Huihui Jiang, Xianzhen Yang, Yi Li, Weipin Niu, Denglu Zhang · 2024 · Frontiers in Immunology
  85. Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models
    Charlotte Jessica E. Metcalf, Bryan Thomas Grenfell, Andrea L. Graham · 2020 · PLoS Pathogens
  86. Illuminating the immunopathology of SARS‐CoV ‐2
    Suraj Saksena, Pratip K. Chattopadhyay · 2021 · Cytometry Part B Clinical Cytometry
  87. Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines
    José Ernesto Belizário · 2021 · Brazilian Journal of Medical and Biological Research
  88. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19
    Jorge Monserrat, Ángel Asúnsolo, Ana Maria Gomez-Lahoz, Miguel Angel Ortega, Jose Gasalla-Herraiz, Óscar Gasulla, Jordi Fortuny-Profitós, Ferran A. Mazaira‐Font, Miguel Teixidó Román, Alberto Arranz et al. · 2021 · Biomedicines
  89. Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy
    Valentino D’Onofrio, L. Z. van Keulen, Annelore Vandendriessche, Jasperina Dubois, Reinoud Cartuyvels, Marie-Elena Vanden Abeele, Judith Fraussen, Patrick Vandormael, Veerle A Somers, Ruth Achten et al. · 2022 · Scientific Reports
  90. New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
    Soo‐Jeung Park, Da‐Eun Nam, Hae Chang Seong, Young S. Hahn · 2022 · Frontiers in Immunology
  91. SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity
    Inès Ait Belkacem, Celia Cartagena García, Ewa Millet-Wallisky, Nicolas Izquierdo, Marie Loosveld, Isabelle Arnoux, Pierre‐Emmanuel Morange, Franck Galland, Nathalie C. Lambert, Fabrice Malergue et al. · 2022 · Scientific Reports
  92. Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals
    Anouk von Borstel, Thi H. O. Nguyen, Louise C. Rowntree, Thomas M. Ashhurst, Lilith F. Allen, Lauren J. Howson, Natasha E. Holmes, Olivia Catherine Smibert, Jason Anthony Trubiano, Claire L. Gordon et al. · 2023 · Immunology and Cell Biology
  93. Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
    Haridha Shivram, Jason A. Hackney, Carrie M. Rosenberger, Anastasia A. Teterina, Aditi Qamra, Olusegun O. Onabajo, Jacqueline McBride, Fang Cai, Min Bao, Larry W. Tsai et al. · 2023 · iScience
  94. T cell responses to SARS-CoV-2 in humans and animals
    Sameer-ul-Salam Mattoo, Jinjong Myoung · 2022 · The Journal of Microbiology
  95. Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
    Alberto Pérez‐Gómez, Carmen Gasca‐Capote, Joana Vitallé, Francisco José Ostos, Ana Serna‐Gallego, María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Teresa Giráldez‐Pérez, Julia Praena‐Segovia, María Dolores Navarro-Amuedo et al. · 2022 · Clinical and Translational Medicine
  96. Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model
    Seungjin Ryu, Irina Shchukina, Yun‐Hee Youm, Hua Qing, Brandon K. Hilliard, Tamara Dlugos, Xinbo Zhang, Yuki Yasumoto, Carmen Jane Booth, Carlos F Fernandez-Hernando et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients
    Benedetta Sposito, Achille Broggi, Laura Pandolfi, Stefania Crotta, Roberto Ferrarese, Sofia Sisti, Nicola Clementi, Alessandro Ambrosi, Enju Liu, Vanessa Frangipane et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity
    Quy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal Mihiranga Gamage, Le Min Tan, Prasanna Nori Venkatesh, Wharton O. Y. Chan, Dilip Kumar, Ragini Agrawal, Yao Chen, Siew‐Wai Fong et al. · 2024 · Nature Communications
  99. The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years
    Otto O. Yang · 2025 · The Journal of Immunology
  100. Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
    Massimo Imazio, Cristina Basso, Antonio Luca Brucato, Karin Klingel, Petr Kuchynka, George A. Lazaros, Marco Merlo, Gianfranco Sinagra, Yehuda Adler, Chiara Bucciarelli‐Ducci et al. · 2025 · European Heart Journal